Market Overview:
The global aclidinium bromide market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The hospital segment is expected to hold the dominant share in the global aclidinium bromide market during the forecast period. North America is estimated to be the leading region for aclidinium bromide market, followed by Europe and Asia Pacific.
Product Definition:
Aclidinium Bromide is an inhaled medication used to treat chronic obstructive pulmonary disease (COPD). It helps to open airways and make breathing easier.
322µg:
The International Agency for Research on Cancer (IARC) has classified the use of brominated Flame Retardants as a possible carcinogen. The agency also stated that exposure to these chemicals may cause cancer in humans and animals by inhalation, ingestion or absorption through the skin. This regulatory move affected all flame retardant products including Aclidinium Bromide, thus limiting its usage in various industries such as textiles, automotive and electrical & electronics sectors among others.
340µg:
The 340ug is a small quantity of antibody, which is used as an ingredient in the preparation of ACL (Aclidinium Bromide) for diagnostic and therapeutic purposes. It helps in diagnosing various heart diseases such as rheumatic heart disease, hypertensive heart disease and congenital long QT syndrome among others. The product also finds application in the treatment of these disorders through cardioplegia or cardiac arrest procedures.
Application Insights:
The global aclidinium bromide market is segmented based on application into hospital and drug store. The hospital application dominated the overall market in terms of revenue share at over 70% in 2017. This high share is attributable to the growing number of hospitals and healthcare centers across the globe, which are increasingly using this medication for treating respiratory problems such as asthma bronchitis, coughs & colds.
Aclidinium bromide also has a wide range of applications in other medical fields such as eye drops, ear drops nose drop etc., where it is used to treat various diseases related to these body parts including runny noses skin infections etc., It can be purchased without prescription only if you have an authentic local medical certificate that states your illness & condition accurately along with relevant laboratory tests performed by doctors approved by government authorities responsible for health issues pertaining to Bromhexine usage worldwide.
Regional Analysis:
North America was the largest regional market in 2017 owing to high product demand for treatment of respiratory disorders. The region is expected to maintain its dominance over the forecast period due to increasing geriatric population, rising number of hospital admissions and improved access resulting in higher usage rates.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast years on account of improving healthcare infrastructure, rising patient awareness levels coupled with an increase in spending capacity especially by private organizations. Moreover, economic development and improvement in living standards are likely to boost demand for aclidinium bromide tablets over coming years.
Growth Factors:
- Increasing prevalence of respiratory diseases: The increasing prevalence of respiratory diseases is one of the major growth drivers for the aclidinium bromide market. Aclidinium bromide is used for the treatment of chronic obstructive pulmonary disease (COPD) and asthma, which are among the most common respiratory diseases. According to a study by The Lancet, COPD is estimated to affect around 384 million people worldwide in 2015, and this number is expected to increase to 456 million by 2030. This growing population base will create demand for aclidinium bromide and drive market growth.
- Rising awareness about COPD: There is a growing awareness about COPD among patients and healthcare professionals alike. This has led to an increased uptake of aclidinium bromide as a treatment option for COPD patients. Additionally, manufacturers are focusing on educating healthcare professionals about the benefits of using aclidinium bromide in order to boost sales volumes.
- Growing geriatric population: The global geriatric population is increasing at an alarming rate due to improvements in health care facilities and lifestyle changes among older people across the world .This trend will lead to an increase in cases of respiratory diseases such as asthma and COPD, creating demand for treatments such as aclidinium bromide .Thus, the rising geriatric population will be another key driver for market growth over the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Aclidinium Bromide Market Research Report
By Type
322µg, 340µg, 400µg
By Application
Hospital, Drug Store
By Companies
Menarini, Almirall, AstraZeneca, Berlin Chemie, Boc Sciences, Circassia Pharmaceuticals, Teva, Yuhao Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
249
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global Aclidinium Bromide Market Report Segments:
The global Aclidinium Bromide market is segmented on the basis of:
Types
322µg, 340µg, 400µg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drug Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Menarini
- Almirall
- AstraZeneca
- Berlin Chemie
- Boc Sciences
- Circassia Pharmaceuticals
- Teva
- Yuhao Chemical
Highlights of The Aclidinium Bromide Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 322µg
- 340µg
- 400µg
- By Application:
- Hospital
- Drug Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Aclidinium Bromide Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Aclidinium bromide is a medication used to treat high blood pressure. It works by reducing the amount of blood that flows through your veins. This can lower your blood pressure and help to prevent heart problems. Aclidinium bromide is also used to treat other conditions, such as angina (chest pain), arrhythmia (irregular heartbeat), and heart failure.
Some of the major companies in the aclidinium bromide market are Menarini, Almirall, AstraZeneca, Berlin Chemie, Boc Sciences, Circassia Pharmaceuticals, Teva, Yuhao Chemical.
The aclidinium bromide market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Aclidinium Bromide Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Aclidinium Bromide Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Aclidinium Bromide Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Aclidinium Bromide Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Aclidinium Bromide Market Size & Forecast, 2018-2028
4.5.1 Aclidinium Bromide Market Size and Y-o-Y Growth
4.5.2 Aclidinium Bromide Market Absolute $ Opportunity
Chapter 5 Global Aclidinium Bromide Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Aclidinium Bromide Market Size Forecast by Type
5.2.1 322µg
5.2.2 340µg
5.2.3 400µg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Aclidinium Bromide Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Aclidinium Bromide Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drug Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Aclidinium Bromide Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Aclidinium Bromide Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Aclidinium Bromide Analysis and Forecast
9.1 Introduction
9.2 North America Aclidinium Bromide Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Aclidinium Bromide Market Size Forecast by Type
9.6.1 322µg
9.6.2 340µg
9.6.3 400µg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Aclidinium Bromide Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drug Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Aclidinium Bromide Analysis and Forecast
10.1 Introduction
10.2 Europe Aclidinium Bromide Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Aclidinium Bromide Market Size Forecast by Type
10.6.1 322µg
10.6.2 340µg
10.6.3 400µg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Aclidinium Bromide Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drug Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Aclidinium Bromide Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Aclidinium Bromide Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Aclidinium Bromide Market Size Forecast by Type
11.6.1 322µg
11.6.2 340µg
11.6.3 400µg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Aclidinium Bromide Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drug Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Aclidinium Bromide Analysis and Forecast
12.1 Introduction
12.2 Latin America Aclidinium Bromide Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Aclidinium Bromide Market Size Forecast by Type
12.6.1 322µg
12.6.2 340µg
12.6.3 400µg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Aclidinium Bromide Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drug Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Aclidinium Bromide Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Aclidinium Bromide Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Aclidinium Bromide Market Size Forecast by Type
13.6.1 322µg
13.6.2 340µg
13.6.3 400µg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Aclidinium Bromide Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drug Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Aclidinium Bromide Market: Competitive Dashboard
14.2 Global Aclidinium Bromide Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Menarini
14.3.2 Almirall
14.3.3 AstraZeneca
14.3.4 Berlin Chemie
14.3.5 Boc Sciences
14.3.6 Circassia Pharmaceuticals
14.3.7 Teva
14.3.8 Yuhao Chemical
